PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2960554-0	1987	Suppression of c-mos expression in teratocarcinoma cells with a new type of inducer of differentiation, 3,5-di-tert-butylchalcone 4"-carboxylic acid.	thiazolidine-4-carboxylic acid	130-148	Moloney sarcoma oncogene	Mus musculus	15-20	
2960554-1	1987	The treatment of 311 cells, a pluripotent mouse teratocarcinoma cell line, with a new type of inducer, 3,5-di-tert-butylchalcone 4"-carboxylic acid (Ch55), results in the suppression of the c-mos gene, accompanied by early marker changes associated with cell differentiation, i.e., the enhanced secretion of plasminogen activator and the decrease in peanut agglutinin receptors and glucose transport.	thiazolidine-4-carboxylic acid	129-147	Moloney sarcoma oncogene	Mus musculus	190-195